<p>This group represents a predicted acid sphingomyelinase-like phosphodiesterase (ASMLPD). The ASMLPD 3b precursor has a possible interaction with the anti-CD20 monoclonal antibodies called rituximab [<cite idref="PUB00043440"/>]. This indicates that it may have a role in immune responses. </p>